Production (Stage)
Elevation Oncology, Inc.
ELEV
$0.3817
$0.00150.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.97M | 4.00M | 3.84M | 4.41M | 3.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.84M | 10.64M | 13.23M | 10.96M | 9.87M |
| Operating Income | -10.84M | -10.64M | -13.23M | -10.96M | -9.87M |
| Income Before Tax | -14.21M | -10.43M | -12.87M | -10.45M | -10.70M |
| Income Tax Expenses | 6.00K | 9.00K | 12.00K | 11.00K | 11.00K |
| Earnings from Continuing Operations | -14.21M | -10.44M | -12.88M | -10.46M | -10.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.21M | -10.44M | -12.88M | -10.46M | -10.71M |
| EBIT | -10.84M | -10.64M | -13.23M | -10.96M | -9.87M |
| EBITDA | -10.84M | -10.64M | -13.22M | -10.96M | -9.86M |
| EPS Basic | -0.24 | -0.18 | -0.22 | -0.18 | -0.21 |
| Normalized Basic EPS | -0.11 | -0.11 | -0.14 | -0.11 | -0.12 |
| EPS Diluted | -0.24 | -0.18 | -0.22 | -0.18 | -0.21 |
| Normalized Diluted EPS | -0.11 | -0.11 | -0.14 | -0.11 | -0.12 |
| Average Basic Shares Outstanding | 59.17M | 59.12M | 59.11M | 59.02M | 51.81M |
| Average Diluted Shares Outstanding | 59.17M | 59.12M | 59.11M | 59.02M | 51.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |